Microglial autophagy in Alzheimer's disease and Parkinson's disease
- PMID: 36704504
- PMCID: PMC9872664
- DOI: 10.3389/fnagi.2022.1065183
Microglial autophagy in Alzheimer's disease and Parkinson's disease
Abstract
Alzheimer's disease (AD) and Parkinson's disease (PD) are the most common neurodegenerative diseases, characterized by gradual and selective loss of neurons in the central nervous system. They affect more than 50 million people worldwide, and their incidence increases with age. Although most cases of AD and PD are sporadic, some are caused by genetic mutations that are inherited. Both sporadic and familial cases display complex neuropathology and represent the most perplexing neurological disorders. Because of the undefined pathogenesis and complex clinical manifestations, there is still no effective treatment for both AD and PD. Understanding the pathogenesis of these important neurodegenerative diseases is important for developing successful therapies. Increasing evidence suggests that microglial autophagy is associated with the pathogenesis of AD and PD, and its dysfunction has been implicated in disease progression. In this review, we focus on the autophagy function in microglia and its dysfunction in AD and PD disease models in an attempt to help our understanding of the pathogenesis and identifying new therapeutic targets of AD and PD.
Keywords: AD; PD; autophagy; microglia; neurodegeneration.
Copyright © 2023 Wang, Wang, Li, Li, Yang and He.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures


Similar articles
-
Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.Eur J Med Chem. 2019 May 1;169:185-199. doi: 10.1016/j.ejmech.2019.03.009. Epub 2019 Mar 8. Eur J Med Chem. 2019. PMID: 30877973 Review.
-
Naringenin: A prospective therapeutic agent for Alzheimer's and Parkinson's disease.J Food Biochem. 2022 Dec;46(12):e14415. doi: 10.1111/jfbc.14415. Epub 2022 Sep 15. J Food Biochem. 2022. PMID: 36106706 Review.
-
The Innate and Adaptive Immune Cells in Alzheimer's and Parkinson's Diseases.Oxid Med Cell Longev. 2022 Sep 28;2022:1315248. doi: 10.1155/2022/1315248. eCollection 2022. Oxid Med Cell Longev. 2022. PMID: 36211819 Free PMC article. Review.
-
Therapeutic Potential of Vital Transcription Factors in Alzheimer's and Parkinson's Disease With Particular Emphasis on Transcription Factor EB Mediated Autophagy.Front Neurosci. 2021 Dec 14;15:777347. doi: 10.3389/fnins.2021.777347. eCollection 2021. Front Neurosci. 2021. PMID: 34970114 Free PMC article. Review.
-
Impaired autophagy in microglia aggravates dopaminergic neurodegeneration by regulating NLRP3 inflammasome activation in experimental models of Parkinson's disease.Brain Behav Immun. 2021 Jan;91:324-338. doi: 10.1016/j.bbi.2020.10.010. Epub 2020 Oct 8. Brain Behav Immun. 2021. PMID: 33039664
Cited by
-
Proteostasis and neurodegeneration: a closer look at autophagy in Alzheimer's disease.Front Aging Neurosci. 2023 Nov 2;15:1281338. doi: 10.3389/fnagi.2023.1281338. eCollection 2023. Front Aging Neurosci. 2023. PMID: 38020769 Free PMC article. Review.
-
The Role of S6K1 in Aging and Alzheimer's Disease: Mechanistic Insights and Therapeutic Potential.Int J Mol Sci. 2025 Jun 20;26(13):5923. doi: 10.3390/ijms26135923. Int J Mol Sci. 2025. PMID: 40649702 Free PMC article. Review.
-
The role of autophagy in brain health and disease: Insights into exosome and autophagy interactions.Heliyon. 2024 Oct 4;10(21):e38959. doi: 10.1016/j.heliyon.2024.e38959. eCollection 2024 Nov 15. Heliyon. 2024. PMID: 39524893 Free PMC article. Review.
-
From Fundamentals to Innovation in Alzheimer's Disease: Molecular Findings and Revolutionary Therapies.Int J Mol Sci. 2024 Nov 16;25(22):12311. doi: 10.3390/ijms252212311. Int J Mol Sci. 2024. PMID: 39596378 Free PMC article. Review.
-
Berberine Rescues D-Ribose-Induced Alzheimer's Pathology via Promoting Mitophagy.Int J Mol Sci. 2023 Mar 20;24(6):5896. doi: 10.3390/ijms24065896. Int J Mol Sci. 2023. PMID: 36982968 Free PMC article.
References
-
- Abiega O., Beccari S., Diaz-Aparicio I., Nadjar A., Layé S., Leyrolle Q., et al. . (2016). Neuronal hyperactivity disturbs ATP microgradients, impairs microglial motility, and reduces phagocytic receptor expression triggering apoptosis/microglial phagocytosis uncoupling. PLoS Biol. 14:e1002466. doi: 10.1371/journal.pbio.1002466, PMID: - DOI - PMC - PubMed
-
- Ahmed S., Kwatra M., Ranjan Panda S., Murty U. S. N., Naidu V. G. M. (2021). Andrographolide suppresses NLRP3 inflammasome activation in microglia through induction of parkin-mediated mitophagy in in-vitro and in-vivo models of Parkinson disease. Brain Behav. Immun. 91, 142–158. doi: 10.1016/j.bbi.2020.09.017, PMID: - DOI - PubMed
-
- Anglade P., Vyas S., Hirsch E. C., Agid Y. (1997). Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease. Histol. Histopathol. 12, 603–610. - PubMed
Publication types
LinkOut - more resources
Full Text Sources